Reverse genetic characterization of the natural genomic deletion in SARS-Coronavirus strain Frankfurt-1 open reading frame 7b reveals an attenuating function of the 7b protein in-vitro and in-vivo.
During the outbreak of SARS in 2002/3, a prototype virus was isolated from a patient in Frankfurt/Germany (strain Frankfurt-1). As opposed to all other SARS-Coronavirus strains, Frankfurt-1 has a 45-nucleotide deletion in the transmembrane domain of its ORF 7b protein. When over-expressed in HEK 293 cells, the full-length protein but not the variant with the deletion caused interferon beta induction and cleavage of procaspase 3. To study the role of ORF 7b in the context of virus replication, we cloned a full genome cDNA copy of Frankfurt-1 in a bacterial artificial chromosome downstream of a T7 RNA polymerase promoter. Transfection of capped RNA transcribed from this construct yielded infectious virus that was indistinguishable from the original virus isolate. The presumed Frankfurt-1 ancestor with an intact ORF 7b was reconstructed. In CaCo-2 and HUH7 cells, but not in Vero cells, the variant carrying the ORF 7b deletion had a replicative advantage against the parental virus (4- and 6-fold increase of virus RNA in supernatant, respectively). This effect was neither associated with changes in the induction or secretion of type I interferon, nor with altered induction of apoptosis in cell culture. However, pretreatment of cells with interferon beta caused the deleted virus to replicate to higher titers than the parental strain (3.4-fold in Vero cells, 7.9-fold in CaCo-2 cells). In Syrian Golden Hamsters inoculated intranasally with 10e4 plaque forming units of either virus, mean titers of infectious virus and viral RNA in the lungs after 24 h were increased 23- and 94.8-fold, respectively, with the deleted virus. This difference could explain earlier observations of enhanced virulence of Frankfurt-1 in Hamsters as compared to other SARS-Coronavirus reference strains and identifies the SARS-CoV 7b protein as an attenuating factor with the SARS-Coronavirus genome. Because attenuation was focused on the early phase of infection in-vivo, ORF 7b might have contributed to the delayed accumulation of virus in patients that was suggested to have limited the spread of the SARS epidemic.
Pfefferle
Susanne
S
Clinical Virology Group, Bernhard Nocht Institute for Tropical Medicine, Hamburg, Germany. pfefferle@bni-hamburg.de
Krähling
Verena
V
Ditt
Vanessa
V
Grywna
Klaus
K
Mühlberger
Elke
E
Drosten
Christian
C
D000818:Animals; D002460:Cell Line; D002522:Chlorocebus aethiops; D022202:Chromosomes, Artificial, Bacterial; D006224:Cricetinae; D005822:Genetic Vectors; D006801:Humans; D008168:Lung / Q000821:virology; D008647:Mesocricetus; D008969:Molecular Sequence Data; D045473:Severe acute respiratory syndrome-related coronavirus / Q000235:genetics* / Q000472:pathogenicity*; D017422:Sequence Analysis, DNA; D017384:Sequence Deletion; D045169:Severe Acute Respiratory Syndrome / Q000473:pathology / Q000821:virology; D014764:Viral Proteins / Q000235:genetics / Q000502:physiology*; D014774:Virulence; D037521:Virulence Factors / Q000235:genetics / Q000502:physiology*; D014779:Virus Replication
C515314:ORF7b protein, SARS coronavirus; D014764:Viral Proteins; D037521:Virulence Factors
Curr Top Microbiol Immunol. 2005;287:161-97
15609512
Emerg Infect Dis. 2006 Dec;12(12):1834-40
17326933
Virus Res. 2008 Apr;133(1):101-12
17451827
Virology. 2003 Mar 30;308(1):13-22
12706086
Avian Pathol. 2005 Dec;34(6):439-48
16537157
J Virol. 2002 Nov;76(22):11518-29
12388713
Virol J. 2006 Aug 31;3:63
16945126
Science. 2003 May 30;300(5624):1394-9
12730500
J Virol. 2007 Feb;81(4):1848-57
17151094
J Virol. 2007 Sep;81(18):9812-24
17596301
J Virol. 2005 Feb;79(3):1595-604
15650185
J Virol. 2005 Dec;79(23):14909-22
16282490
J Gen Virol. 2001 Jun;82(Pt 6):1273-1281
11369870
Lancet. 2003 Jul 26;362(9380):263-70
12892955
J Biol Chem. 2007 Nov 2;282(44):32208-21
17761676
Virology. 2002 Apr 25;296(1):177-89
12036329
J Virol. 2007 Oct;81(20):11054-68
17686858
J Virol. 1998 May;72(5):4508-14
9557750
N Engl J Med. 2003 May 15;348(20):1953-66
12690092
Virus Res. 2008 Apr;133(1):20-32
17499378
Virology. 2007 Apr 25;361(1):18-26
17316733
J Virol. 2002 May;76(9):4655-61
11932433
Int J Mol Med. 2005 Feb;15(2):323-7
15647850
J Virol. 2006 Jun;80(11):5168-78
16698997
J Mol Biol. 2003 Aug 29;331(5):991-1004
12927536
J Virol. 2007 Mar;81(6):2554-63
17182678
Science. 2003 Oct 10;302(5643):276-8
12958366
Philos Trans R Soc Lond B Biol Sci. 2004 Jul 29;359(1447):1091-105
15306395
Science. 2004 Mar 12;303(5664):1666-9
14752165
Proc Natl Acad Sci U S A. 2000 May 9;97(10):5516-21
10805807
J Virol. 2002 Nov;76(21):11065-78
12368349
J Virol. 2008 Oct;82(19):9477-91
18632859
J Virol. 2007 Jan;81(2):718-31
17079322
Virol J. 2006 Mar 29;3:17
16571117
Emerg Infect Dis. 2005 Jan;11(1):168-70
15714661
Curr Top Microbiol Immunol. 2005;287:199-227
15609513
Gene. 1991 Dec 15;108(2):193-9
1660837
Lancet. 2003 May 24;361(9371):1767-72
12781535
N Engl J Med. 2003 May 15;348(20):1967-76
12690091
Trends Mol Med. 2003 Aug;9(8):325-7
12928032
Proc Natl Acad Sci U S A. 2004 Apr 20;101(16):6146-51
15071187
J Infect Dis. 2006 Sep 15;194(6):808-13
16941348
J Virol. 2004 Nov;78(22):12683-8
15507657
J Virol. 2004 Dec;78(24):14043-7
15564512
Proc Natl Acad Sci U S A. 2003 Oct 28;100(22):12995-3000
14569023
Am J Pathol. 2008 Jun;172(6):1625-37
18467696
J Virol. 2007 Jan;81(2):548-57
17108024
J Gen Virol. 2003 Sep;84(Pt 9):2305-2315
12917450
PLoS Pathog. 2007 Aug 10;3(8):e109
17696607
J Clin Virol. 2004 Jul;30(3):211-3
15135736
Science. 1981 Nov 20;214(4523):916-9
6272391
J Virol. 2004 Apr;78(8):3863-71
15047802
J Virol. 2000 Nov;74(22):10600-11
11044104
Cancer Res. 1993 Sep 1;53(17):3976-85
8358726
Cell Mol Life Sci. 2004 Aug;61(16):2100-12
15316659
J Virol. 2007 Jun;81(12):6346-55
17428862
Proc Natl Acad Sci U S A. 2005 Sep 27;102(39):14040-5
16169905
J Virol. 2006 Aug;80(15):7481-90
16840328
J Virol. 1987 Dec;61(12):3809-19
3479621
Rev Sci Tech. 2004 Aug;23(2):643-60
15702725
J Virol. 2005 Feb;79(4):2001-9
15681402
J Virol. 2006 Apr;80(7):3670-4
16537637
Proc Natl Acad Sci U S A. 2000 Oct 24;97(22):12289-94
11027311
Nucleic Acids Res. 1984 Jun 25;12(12):5123-41
6330698
Virology. 1995 Oct 1;212(2):622-31
7571432
J Virol. 2005 Jan;79(1):503-11
15596843
N Engl J Med. 2003 Dec 18;349(25):2431-41
14681510
PLoS Pathog. 2008 May 02;4(5):e1000054
18451981
J Virol. 2006 Nov;80(21):10900-6
16928748
Proc Natl Acad Sci U S A. 1986 Apr;83(8):2330-4
3010307
J Virol. 2005 Jun;79(11):7095-103
15890949
Adv Exp Med Biol. 2006;581:149-52
17037522
Science. 2005 Oct 28;310(5748):676-9
16195424